Skip to content

Investigation of the prophylactic effects of lisinopril on chronic migraine

Investigation of the prophylactic effects of lisinopril in comparison to placebo on chronic migraine

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201701089157N5
Enrollment
112
Registered
2017-06-14
Start date
2017-06-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

migraine.

Interventions

Intervention 1: After the eligibility criteria will be applied, 112 chronic migraineurs will be selected and randomly allocated to placebo or intervention groups. Upon admission, a headache questionna
Treatment - Drugs
Placebo
After the eligibility criteria will be applied, 112 chronic migraineurs will be selected and randomly allocated to placebo or intervention groups. Upon admission, a headache questionnaire will be give

Sponsors

Iranian Center of Neurological Research, Tehran University of Medical Sciences,
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Patients will be included in the study due to the following inclusion Criteria: having = 15 headache days per month for at least 3 months, history of migraine for at least 1 year, age 18-45 years, systolic blood pressure between 110-140 mmHg Taking a large amount of abortive drugs. The exclusion criteria were as follows: having psychiatric illness, having major neurological disorders and / or other chronic or systemic diseases, being pregnant or have a planned pregnancy, breastfeeding, taking prophylactic medications in the last 4 weeks, suffering from impaired liver function or kidney disorders, allergies to ACE inhibitors, history of angionearotic edema suffering from secondary headaches.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Migraine headache severity. Timepoint: first month, second month, third month. Method of measurement: Visual Analog Scale (VAS).;Migraine headache duration. Timepoint: first month, second month, third month. Method of measurement: Migraine headache diary.;Migraine headache frequency. Timepoint: first month, second month, third month. Method of measurement: Migraine headache diary.

Secondary

MeasureTime frame
Remission from Chronic Migraine to Episodic Migraine. Timepoint: first week, second month. Method of measurement: physical examination, headache diary.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactProf. Mansoureh Togha

Sina Hospital, Tehran University of Medical Sciences

toghae@sina.tums.ac.ir+98 21 6670 2052

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026